Elekta has appointed Jakob Just-Bomholt as its new President and CEO, effective September 1, 2025, the medical technology firm announced.
Just-Bomholt, who will join in August for onboarding, previously served as CEO of dental technology company 3Shape and held senior executive positions at Falck A/S and A/P Moller Maersk, according to the company.
Elekta’s Founder and Chairman, Dr Laurent Leksell, said, "His strategic leadership and international experience, combined with a proven ability to drive profitable growth and global expansion through customer-focused innovation and operational excellence, make him very well-suited to lead Elekta forward."
"I am honored to join Elekta, a company with a proud legacy and a powerful mission to improve the lives of people with cancer," Just-Bomholt stated. "Radiation therapy plays a vital role in modern oncology, and I look forward to working with the talented team at Elekta to continue delivering life-changing solutions to patients around the world."
Elekta specializes in precision radiation therapy solutions for cancer treatment.
More from this issuer
Related coverage
Elekta's new chief executive is replacing three top executives, including the finance chief, in a broad management overhaul aimed at improving the Swedish medical-device maker's performance.
Elekta AB has introduced a new long-term incentive plan that ties executive bonuses to the sales of its advanced radiation-therapy technology, a move approved at its annual general meeting on Thursday.
Elekta AB reported a drop in first-quarter sales and profit margins, setting a challenging backdrop for incoming Chief Executive Jakob Just-Bomholt.
Elekta AB said it received U.S. regulatory clearance for its Leksell Gamma Knife radiosurgery system to treat a form of drug-resistant epilepsy in adults.